Form 4: Clifford Sosin of CAS Investment Partners Acquires 350,000 Shares of Cardlytics, Inc.

Clifford Sosin, Managing Member of CAS Investment Partners, reports the acquisition of 350,000 shares of Cardlytics, Inc. at a price of $14.1601 per share.

Summary

• On March 19, 2024, Clifford Sosin acquired 350,000 shares of Cardlytics, Inc. (CDLX) common stock.
• The purchase price was $14.1601 per share.
• Following the transaction, Sosin's total beneficial ownership in Cardlytics is 6,373,676 shares.
• These shares are held indirectly through Sosin Master, L.P. and CSWR Partners, L.P., for which CAS Investment Partners, LLC acts as the investment manager.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A major shareholder increasing their stake can be seen as a vote of confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

• The acquisition of a significant number of shares by a major investor could be seen as a positive signal for the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or major shareholders of a publicly traded company buy or sell shares. This filing indicates a purchase, which can sometimes be interpreted as a sign of confidence in the company's future performance.

Stakeholder Impact

• Shareholders may view this purchase positively, potentially leading to a slight increase in stock price.

Key Dates